(Carnegie Mellon University) Physicians will be able to predict which of their patients with severe asthma are likely to benefit from treatment with systemic corticosteroids — and which might only suffer their side effects — with help from a dozen clinical variables researchers have identified using machine learning techniques, say researchers at Carnegie Mellon University and the University of Pittsburgh School of Medicine.

Original source: https://www.eurekalert.org/pub_releases/2019-02/cmu-nmi021919.php